Taipei, Taiwan

Chi-Kun Ohyang

This inventor holds 6 USPTO granted patents. Top assignee: Liqbio Biomedical Company Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi-Kun Ohyang. Retrieved from https://idiyas.com/inventor/chi-kun-ohyang-13rc6zmt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Chi-Kun Ohyang

Introduction

Chi-Kun Ohyang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly through his innovative designs and patents. With a total of 6 patents to his name, Ohyang continues to push the boundaries of technology in healthcare.

Latest Patents

One of his latest inventions is the "Cell Flow Channel," which aims to enhance the efficiency of cellular processes in biomedical applications. This invention showcases his commitment to improving medical technologies and patient care.

Career Highlights

Chi-Kun Ohyang is currently employed at Liqbio Biomedical Company Limited, where he applies his expertise to develop cutting-edge solutions in the biomedical sector. His work at this company has positioned him as a key player in the industry, contributing to advancements that have the potential to revolutionize healthcare.

Collaborations

Throughout his career, Ohyang has collaborated with talented individuals such as Tzu-Keng Chiu and Yu-Xian Zhu. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Chi-Kun Ohyang's contributions to the field of biomedical engineering are noteworthy. His inventions, particularly the Cell Flow Channel, reflect his dedication to advancing medical technology. As he continues to innovate, the impact of his work will undoubtedly be felt in the healthcare industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…